Corteva (NYSE:CTVA) Issues FY 2026 Earnings Guidance

Corteva (NYSE:CTVA) updated its FY 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 3.450-3.700 for the period, compared to the consensus earnings per share estimate of 3.230. The company issued revenue guidance of -, compared to the consensus revenue estimate of $18.4 billion.

Corteva Stock Up 0.2%

Corteva stock traded up $0.12 during trading on Wednesday, reaching $75.16. The stock had a trading volume of 1,382,918 shares, compared to its average volume of 3,730,709. The company has a quick ratio of 1.07, a current ratio of 1.58 and a debt-to-equity ratio of 0.07. Corteva has a 52-week low of $53.40 and a 52-week high of $77.41. The stock has a market cap of $50.79 billion, a PE ratio of 32.16, a P/E/G ratio of 1.86 and a beta of 0.75. The business has a 50 day moving average price of $68.44 and a 200 day moving average price of $68.35.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.22. The business had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a net margin of 9.19% and a return on equity of 9.37%. The company’s revenue for the quarter was down 1.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, analysts predict that Corteva will post 2.96 EPS for the current year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is 30.77%.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Wall Street Zen upgraded shares of Corteva from a “hold” rating to a “buy” rating in a research note on Saturday, January 17th. Wolfe Research upped their target price on shares of Corteva from $80.00 to $81.00 and gave the company an “outperform” rating in a report on Friday, January 16th. Citigroup lifted their price target on shares of Corteva from $70.00 to $74.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 21st. The Goldman Sachs Group upped their price objective on shares of Corteva from $77.00 to $78.00 and gave the company a “buy” rating in a research note on Tuesday, December 16th. Finally, JPMorgan Chase & Co. raised their price objective on Corteva from $70.00 to $75.00 and gave the stock an “overweight” rating in a report on Wednesday, January 21st. Two research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $79.58.

Institutional Trading of Corteva

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. JPL Wealth Management LLC acquired a new stake in Corteva in the third quarter valued at $25,000. Measured Wealth Private Client Group LLC purchased a new position in shares of Corteva in the 3rd quarter valued at about $33,000. Binnacle Investments Inc lifted its stake in shares of Corteva by 54.7% in the second quarter. Binnacle Investments Inc now owns 512 shares of the company’s stock valued at $38,000 after purchasing an additional 181 shares during the period. Sunbelt Securities Inc. boosted its holdings in Corteva by 52.8% during the third quarter. Sunbelt Securities Inc. now owns 923 shares of the company’s stock worth $62,000 after buying an additional 319 shares in the last quarter. Finally, Palisade Asset Management LLC acquired a new position in Corteva during the third quarter worth about $67,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.